Maria-Teresa Peracchia

Sanofi

Maria Teresa Peracchia is the Global Head, Drug Delivery and Product Integration within Biologics Drug Product Development (BioDPD) since 1st March 2019. Maria Teresa joined Sanofi in 1999. Previously (2013-2019) she served as CMC Project Leader for Dupilumab (Dupixent®) developed in collaboration with Regeneron, where she led the CMC team through successful submission, registration and launch of Dupilumab for Atopic Dermatitis and Asthma indications.  Prior to this, Maria-Teresa held several positons of increasing responsibility in the formulation and drug delivery groups within Sanofi. She has authored/ co-authored over 20 publications in the field of drug delivery and filed 8 patents.

Maria-Teresa holds a PhD in Pharmacy from the University of Parma. She was a Visiting Scientist (1992-1994) in Prof. Robert Langer’s lab at MIT, developing PEGylated polymeric nanoparticles (Science, 1994) and a post-doctoral fellow (1995-1998) with Prof. Patrick Couvreur at the University Paris-XI.

Sessions